AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
PowderJect Opposes Vical Inc.'s Core DNA Vaccines Patent.(Brief Article)
2001 NOV 14 - (NewsRx.com & NewsRx.net) -- PowderJect Pharmaceuticals Plc (PJP), a specialty vaccines company, and its wholly owned subsidiary PowderJect Vaccines, Inc., have successfully challenged Vical Inc.'s (VICL) core European patent relating to naked DNA vaccines. As a result of this challenge, mounted by PowderJect and six other parties, the European Patent Office overturned Vical's patent in its entirety, determining that the company's European Patent No. 0 465 529 contained no allowable claims.
PowderJect already holds extensive granted European and U.S. patents covering powder injection of DNA vaccines, giving the company exclusive coverage of this unique immunization technology. Importantly, the opposition process to the Vical patent confirmed that Vical does not claim any ownership of DNA vaccination via powder injection.
"We felt it important to oppose Vical's patent and we are therefore extremely pleased with the ruling," said Charles Swingland, general counsel of PowderJect. "This important case confirms the strength of our ownership of DNA vaccination by powder injection while making the proprietary position relating to liquid delivery uncertain. Following this success in Europe, we are continuing our efforts to expand our robust intellectual property position in the U.S."
Vical, meanwhile, said it intends to appeal the ruling. According to European ...
- Digimarc Receives its First European Patent; European Patent Office Grants...
- Press release article from: Business Wire December 11, 2001 700+ words
...announced today that the European Patent Office in Munich, Germany, has granted the company its first European patent. Patent number EP 0 959...concluded last month. With the European Patent Office process completed and the...
- Veridicom Announces New European Patent; European Patent Office Intends to...
- Press release article from: Business Wire July 21, 2004 700+ words
...International Inc. (OTCBB:VRDI) today announced that the Examining Division of the European Patent Office intends to grant Veridicom a European patent for "Biometric False Accept Detection." "This pending patent award signifies our company...
- European Patent Office.(Verity Inc. and the European Patent Office form...
- Magazine article from: Online May 1, 1999 700+ words
Verity, Inc. and the European Patent Office have formed a strategic relationship...published by the member states of the European Patent Organisation, the European Patent Office, and the World Intellectual Property...
- -EUROPEAN PATENT OFFICE PLANNING ON-LINE PATENT DATABASE.
- Newspaper article from: Telecomworldwire February 2, 1999 700+ words
The European Patent Office and Verity Inc, a provider of knowledge retrieval...patent documents published by the member states of the European Patent Organisation, the European Patent Office (EPO) and the World Intellectual Property Organisation...
- BioChem Pharma's 3TC European Patent Upheld by European Patent Office Emory...
- Press release article from: PR Newswire April 21, 1999 700+ words
...Opposition Division of the European Patent Office (EPO) dismissed Emory University...are very pleased that the European Patent Office has dismissed Emory's opposition to our granted European patent covering 3TC. Today's...
- Acacia Research Affiliate Receives European Patent Office ``Notice of Intention...
- Press release article from: Business Wire March 5, 1999 700+ words
...received a "Notice of Intention to Grant a European Patent" from the European Patent Office for its video-on-demand and audio...rapidly on an international basis. The European Patent Office action strengthens the worldwide intellectual...
- Logica Develops New Management System for European Patent Office; Integration...
- Press release article from: PR Newswire February 15, 2002 700+ words
...5 million euro from the European Patent Office (EPO) to develop a new...on 1 January 2003. The European Patent Office has initiated the BEST...www.logica.com/ . European Patent Office The European Patent Office...
- European Patent Office maintains validity of Angiotech's paclitaxel-eluting...
- Newspaper article from: BIOTECH Patent News January 1, 2005 700+ words
...Canada) announced a favorable decision on its European Patent (0706 376) from the European Patent Office Opposition Division. The European Patent Office maintained the validity of Angiotech's patent with various claims, including claims...
Source: HighBeam Research, PowderJect Opposes Vical Inc.'s Core DNA Vaccines Patent.(Brief...